Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-045749

Chief Executive Officer sold 7,800 shares at an average $37.43 ($291,957)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-08-06 Sale −3,900 $37.48 $146,172 85,978 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-08-07 Sale −3,600 $37.35 $134,460 82,378 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-08-07 Sale −300 $37.75 $11,325 82,078 I: show line 3 in the form
Open-market sales · 7,800 sh · avg $37.43 · $291,957
Loading xslF345X03/doc4.xml…